NCT07146932

Brief Summary

The goal of this clinical trial is to evaluate the safety and effectiveness of the Bambini Teens exoskeleton as a gait training tool in children aged 5 to 14 years diagnosed with cerebral palsy (CP). The main questions it aims to answer are:

  • Is the Bambini Teens exoskeleton device safe and feasible as a gait training intervention for children with cerebral palsy, without resulting in a significant incidence of device-related serious adverse events?
  • Is it feasible for physical therapists to use the Bambini Teens exoskeleton as a gait training intervention for children with cerebral palsy, meaning participants will successfully complete the training sessions?
  • Will participants' mobility, specifically their self-selected walking speed, improve after receiving gait training using the Bambini Teens exoskeleton compared to baseline measurements? Researchers will compare participants' mobility measured at baseline to their mobility after the intervention to see if improvements occur. Participants will:
  • Complete 6 gait training sessions using the Bambini Pediatric Exoskeleton, monitored by a licensed physical therapist.
  • Each training session will be 30 minutes long, conducted 2-3 times per week for approximately 3 weeks.
  • Undergo evaluations at baseline and post-intervention (after approximately 3 weeks), with each evaluation session lasting approximately 2 hours.
  • May also participate in optional motor evaluations.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 13, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

August 28, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

September 22, 2025

Status Verified

September 1, 2025

Enrollment Period

2 months

First QC Date

August 13, 2025

Last Update Submit

September 17, 2025

Conditions

Keywords

Bambini TeensCerebral PalsyExoskeletonExoAtletCosmo RoboticsWearable Robotic Devices

Outcome Measures

Primary Outcomes (4)

  • Device Safety

    Incidence of device-related serious adverse events (SAEs) and other adverse events (AEs) occurring during the intervention period, recorded in an adverse event log.

    Baseline to end of intervention (approximately 3 weeks)

  • Participant Usage and Treatment Compliance

    Proportion of participants who complete all six planned gait training sessions under the supervision of a licensed physical therapist. Completion will be verified by session attendance and completion records.

    Baseline to end of intervention (approximately 3 weeks)

  • Feasibility of Usage

    Proportion of participants for whom the treating physical therapist successfully fits the device and records session-specific device settings, as documented in the session logs.

    Baseline to end of intervention (approximately 3 weeks)

  • Clinician Treatment Satisfaction

    Clinician satisfaction with the intervention, measured using a standardized FORM questionnaire completed by the treating physical therapist at the end of the intervention.

    End of intervention (~3 weeks, at final assessment)

Secondary Outcomes (10)

  • Physical Impairment - Blood Pressure

    Baseline to end of intervention (approximately 3 weeks)

  • Physical Impairment - Muscle Strength

    Baseline to end of intervention (approximately 3 weeks)

  • Physical Impairment - Joint Range of Motion

    Baseline to end of intervention (approximately 3 weeks)

  • Physical Impairment - Spasticity

    Baseline to end of intervention (approximately 3 weeks)

  • Endurance

    Baseline to end of intervention (approximately 3 weeks)

  • +5 more secondary outcomes

Study Arms (1)

Bambini Teens Exoskeleton Gait Training

EXPERIMENTAL

Participants in this arm will receive gait training using the Bambini Teens Exoskeleton. Each participant will complete six training sessions, each lasting 30 minutes, conducted 2-3 times per week over approximately 3 weeks.

Device: Pediatric Lower Limb Exoskeleton (Bambini Teens)

Interventions

The Bambini Teens Exoskeleton is a wearable robotic device developed to assist lower limb movement and facilitate gait training for pediatric patients with mobility impairments such as cerebral palsy. The device provides powered assistance at the hip, knee, and ankle joints, supports adjustable gait parameters, and is designed for use in clinical rehabilitation settings under professional supervision.

Bambini Teens Exoskeleton Gait Training

Eligibility Criteria

Age5 Years - 14 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Between the age of 5 and 14 years and diagnosed with cerebral palsy;
  • have joint range of motion within normal functional limits for ambulation as determined by study staff;
  • Be able and willing to comply with study procedures, including follow-up requirements;
  • Patient cognitive status and ability to communicate must be at a level consistent with that required to participate in standard motor rehabilitation;
  • can follow directions as determined by study staff;
  • be able to physically fit into exoskeleton device; height from 110 to 160 cm (43 to 62 inches) and weighing up less than 65 kg (145 lbs);
  • be able to walk 10 meters with the aid of a walking assistive device and/or a single human assistant;
  • bilateral lower limb spasticity that allows lower limb range of motion within the device.

You may not qualify if:

  • any medical issue that precludes full weight-bearing and ambulation (e.g. orthopedic injuries, pain, severe spasticity);
  • skin issues that would prevent wearing the device;
  • pre-existing condition that caused exercise intolerance;
  • uncontrolled seizure disorder, spasticity or joint contracture that would interfere with walking;
  • neuromuscular, neurological, cardiovascular or orthopedic pathologies that will interfere with neuromuscular function, ambulation, or limit the range of motion of the lower limbs;
  • severe spasticity (Modified Ashworth Scale = or \> 3);
  • hip extension range of motion \< 0 degrees, knee flexion contracture \> 20 degrees, knee valgus \> 40 degrees, 2 or more fractures within the past year, hip subluxation (\> 40% migration),
  • existing Baclofen pump, and/or Botox injections within the past 4 months of study enrollment;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kessler Foundation

West Orange, New Jersey, 07052, United States

Location

MeSH Terms

Conditions

Cerebral Palsy

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 13, 2025

First Posted

August 28, 2025

Study Start

October 1, 2025

Primary Completion

December 1, 2025

Study Completion

January 1, 2026

Last Updated

September 22, 2025

Record last verified: 2025-09

Locations